Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Description

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.

Conditions

Chronic Obstructive Pulmonary Disease

Study Overview

Study Details

Study overview

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Condition
Chronic Obstructive Pulmonary Disease
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Chicago

Northwestern Memorial Hospital, Chicago, Illinois, United States, 60611

Iowa City

University of Iowa, Iowa City, Iowa, United States, 52242

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21287

College Park

University of Maryland, College Park, Maryland, United States, 20742

Boston

Boston VA Hospital, Boston, Massachusetts, United States, 02130

Bloomington

HealthPartners Institute, Bloomington, Minnesota, United States, 55440

Minneapolis

Minnesota VA HealthCare System, Minneapolis, Minnesota, United States, 55455

Chappaqua

Northern Westchester Hospital/Northwell Health, Chappaqua, New York, United States, 10514

Cincinnati

Cincinnati VA Hospital, Cincinnati, Ohio, United States, 45220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 40 or greater
  • 2. Clinical diagnosis of COPD
  • 3. Hospitalized for acute exacerbation of COPD.
  • 4. Be willing to adhere to trial and follow-up procedures and give informed consent
  • 1. Secondary diagnosis of congestive heart failure that is severe as documented by active symptoms, New York Heart Association (NYHA) functional classification IV or left ventricular ejection fraction \<25% on echocardiography
  • 2. Other respiratory conditions that could confound the diagnosis such as asthma, pulmonary fibrosis, bronchiectasis, and lung cancer. Participants with pneumonic exacerbations of COPD will be included.
  • 3. Primary diagnosis of COVID pneumonia. Individuals with incidentally detected COVID or persistently positive for COVID but deemed to be convalescent will not be excluded.
  • 4. Active cancers on chemotherapy or radiation therapy
  • 5. Immunosuppressed states predisposing to frequent hospitalizations including uncontrolled HIV/AIDS
  • 6. Active or recent (within 1 month) myocardial infarction
  • 7. Angina not well-controlled by medication
  • 8. Unstable cardiac arrhythmias, atrial or ventricular
  • 9. Supplemental oxygen requirement greater than 5 liters per minute at either rest or with exertion
  • 10. Significant cognitive dysfunction, including dementia, that in opinion of investigator would impair ability to safely or effectively engage in study protocol
  • 11. Participants with any terminal medical illnesses as diagnosed by a physician, and/or on hospice
  • 12. Currently enrolled in and participating in pulmonary rehabilitation
  • 13. Treatment with chronic or newly initiated home ventilatory support. Those on in-patient short-term non-invasive ventilation will not be excluded.
  • 14. Special patient groups such as prisoners and institutionalized patients
  • 15. Participants with musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program
  • 16. Current participation in any other interventional clinical trial
  • 17. Inability to understand and speak English during exercise sessions
  • 18. Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alabama at Birmingham,

Surya P Bhatt, MD, MSPH, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

2027-08-31